Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine

This page shows you your search results in order of relevance. This is page number 4.

Order by Relevance | Date

Total 1796 results found since Jan 2013.

Herpes Zoster Virus Reactivation in a 16 Year Old Female Post COVID-19 Vaccine. Case report and Review of the Literature
CONCLUSION: Varicella zoster virus falls under the family of Herpesviridae, It's characterized by its ability to escape host immune system and remain dormant in ganglionic neurons. Reactivation of the infection will result in herpes zoster manifesting as painful vesicles in a dermatomal distribution. Possible link is the suppression of type-one interferons caused by the mRNA-based vaccine such as COVID-19 vaccines. Yet, potential correlation remains to be demonstrated.PMID:37260797 | PMC:PMC10227837 | DOI:10.5455/medarh.2023.77.146-149
Source: Herpes - June 1, 2023 Category: Infectious Diseases Authors: Sadan Alharbi Mohammed Alsubaie Remah Alzayyat Batool Alattas Hassan AlAhmadi Hanoof Alabdullatif Source Type: research

Reduced dementia incidence after varicella zoster vaccination in Wales 2013-2020
DISCUSSION: Our study shows a clear association of shingles vaccination with reduced dementia, consistent with other observational cohort studies. The association may reflect selection bias with people choosing to be vaccinated having a higher healthy life expectancy.PMID:35434253 | PMC:PMC9006884 | DOI:10.1002/trc2.12293
Source: Herpes - April 18, 2022 Category: Infectious Diseases Authors: Christian Schnier Janet Janbek Richard Lathe J ürgen Haas Source Type: research

Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis
CONCLUSIONS: Though some ESRD patients on HD had local and systemic AEs after first-dose vaccination, the clinical significance of these symptoms was minor. Our study confirmed the safety profile of ChAdOx1 nCoV-19 in HD patients and presented a new viewpoint on vaccine-related AEs. The SCCS analysis did not find an elevated risk of VAT at 1 month following vaccination. Apart from VAT, other vaccine-related AEs, irrespective of local or systemic symptoms, had minor clinical significance on safety issues. Nonetheless, further coordinated, multi-center, or registry-based studies are needed to establish the causality.PMID:360...
Source: Herpes - September 9, 2022 Category: Infectious Diseases Authors: I-Ning Yang Chin-Li Lu Hung-Jen Tang Yu-Chi Kuo Li-Hwa Tsai Kuan Chieh Tu Jhi-Joung Wang Chih-Chiang Chien Source Type: research

Herpes Zoster Ophthalmicus in a Healthy Toddler Fully Immunized Against Varicella-Zoster Virus: A Case Report and Review of Treatment Strategies in Children
We present a complex case of HZO in a varicella zoster virus (VZV)-vaccinated toddler successfully treated with acyclovir and topical steroids. We also present a review of the relevant literature regarding the therapeutic management and long-term sequelae of HZO in children.PMID:36751223 | PMC:PMC9897126 | DOI:10.7759/cureus.33352
Source: Herpes - February 8, 2023 Category: Infectious Diseases Authors: Paraskevi Keramida Marita Antoniadi Eugenia Archimandritou Stavroula Kostaridou Patra Koletsi Source Type: research

Increased Myocardial Infarction Risk Following Herpes Zoster Infection
CONCLUSIONS: Herpes zoster infection was associated with an increased risk of MI within the first 30 days postinfection. History of prior MI, male sex, age ≥50 years, history of heart failure, peripheral vascular disease, human immunodeficiency virus, prior cerebrovascular accident, and renal disease increased odds of MI 30 days postinfection with herpes zoster. Herpes zoster vaccination decreased the odds of developing an MI in patients aged ≥50 years.PMID:37035490 | PMC:PMC10077824 | DOI:10.1093/ofid/ofad137
Source: Herpes - April 10, 2023 Category: Infectious Diseases Authors: Ganapathi I Parameswaran Alexandra F Drye Bethany A Wattengel Michael T Carter Kathleen M Doyle Kari A Mergenhagen Source Type: research

Similar herpes zoster incidence across Europe: results from a systematic literature review
Background: Herpes zoster (HZ) is caused by reactivation of the varicella-zoster virus (VZV) and mainly affects individuals aged>=50 years. The forthcoming European launch of a vaccine against HZ (Zostavax(R)) prompts the need for a better understanding of the epidemiology of HZ in Europe. Therefore the aim of this systematic review was to summarize the available data on HZ incidence in Europe and to describe age-specific incidence. Methods: The Medline database of the National Library of Medicine was used to conduct a comprehensive literature search of population-based studies of HZ incidence published between 1960 and 20...
Source: BMC Infectious Diseases - April 10, 2013 Category: Infectious Diseases Authors: Sybil PinchinatAna Cebrián-CuencaHélène BricoutRobert Johnson Source Type: research

Could depression be the result of a brain infection?
ConclusionThe paper's hypothesis is interesting, but it remains just that – a hypothesis. While it is true that some pathogens, such as the Borna disease virus mentioned in the article, have been linked with neuropsychiatric disorders, there is no proof as yet that bacteria, viruses or parasites could cause major depression. Still, as the old truism goes: "Absence of evidence is not the same as evidence of absence". The lack of evidence could be because nobody has bothered to look for it before.The author concludes that, "It would be worthwhile to conduct large-scale studies of carefully characterised de...
Source: NHS News Feed - November 28, 2014 Category: Consumer Health News Tags: Mental health Source Type: news

Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine.
CONCLUSIONS: Based on published immunogenicity, efficacy, and safety data, as well as the recent recommendations by the ACIP, HZ/su should be included on both hospital and community pharmacy formularies and recommended to all immunocompetent patients older than 50 years to prevent herpes zoster. PMID: 29457489 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - February 1, 2018 Category: Drugs & Pharmacology Authors: James SF, Chahine EB, Sucher AJ, Hanna C Tags: Ann Pharmacother Source Type: research

Heplisav-B: A Hepatitis B Vaccine With a Novel Adjuvant.
CONCLUSION: HepB-CpG has been shown to be as immunogenic as Engerix-B; however, long-term safety and persistence of immune memory has yet to be established. PMID: 32988213 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - September 27, 2020 Category: Drugs & Pharmacology Authors: Champion CR Tags: Ann Pharmacother Source Type: research

Healthcare workers' perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis
CONCLUSIONS: There is little research focusing specifically on healthcare workers' perceptions and experiences of communication with older adults about vaccination. The studies we identified suggest that healthcare workers differed among themselves in their perceptions about the aim of this communication and about the role of older adults in vaccine decisions. Based on these findings and the other findings in our review, we have developed a set of questions or prompts that may help health system planners or programme managers when planning or implementing strategies for vaccination communication between healthcare workers ...
Source: Cochrane Database of Systematic Reviews - July 20, 2021 Category: General Medicine Authors: Claire Glenton Benedicte Carlsen Simon Lewin Manuela Dominique Wennekes Brita Askeland Winje Renske Eilers VITAL consortium Source Type: research

Pityriasis rosea, pityriasis rosea-like eruptions and herpes zoster in the setting of covid-19 and covid-19 vaccination
Clin Dermatol. 2022 Jan 27:S0738-081X(22)00002-5. doi: 10.1016/j.clindermatol.2022.01.002. Online ahead of print.ABSTRACTPityriasis rosea (PR), pityriasis rosea like eruptions (PR-LEs) and herpes zoster (HZ) have been frequently reported during COVID-19 or following COVID-19 vaccination. PR is a self-limiting exanthematous disease and HZ a treatable condition, therefore their occurrence does not require discontinuation of the vaccination schedule. PR-LE is a hypersensitivity reaction and, therefore, less predictable in its course. In case of booster dose, the clinical manifestation may not recur, may be different from PR-L...
Source: Herpes - January 30, 2022 Category: Infectious Diseases Authors: Francesco Drago Francesco Broccolo Giulia Ciccarese Source Type: research